How many studies have been conducted on Mecamylamine?

BiohacksAI has indexed 298 PubMed studies on Mecamylamine, including 25 randomized controlled trials (RCTs). 21% of studies involve human subjects.

What are the main research areas for Mecamylamine?

The primary research domains for Mecamylamine are 🧠 Learning, 🧠 Memory, 🧠 Focus & Attention. This is based on analysis of 298 PubMed studies using the BiohacksAI evidence platform.

Mecamylamine

A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

298+ PubMed studies analyzed · 25 RCTs · Evidence Score: 41.9

Research Domains

Mecamylamine has been studied across 19 research domains including 🧠 Learning, 🧠 Memory, 🧠 Focus & Attention, 🌤️ Mood & Depression, ❤️ Cardiovascular. The primary research focus is 🧠 Learning with 16% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Mecamylamine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Dimethylphenylpiperazinium

11 shared targets

Arecoline

11 shared targets

Dihydro-beta-Erythroidine

Loading evidence profile...

This evidence profile for Mecamylamine is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.